Clinical Trial

Fiberoptic Evaluation of i-Gel and Air-Q sp3G Supraglottic Airway Devices in Pediatric Patients

Completed
View on ClinicalTrials.gov →
Summary
This single-center, prospective, randomized controlled study aims to compare the placement accuracy of iGel and Air-Q sp3G supraglottic airway (SGA) devices in pediatric patients aged 1-8 years undergoing elective surgery under general anesthesia. Placement will be confirmed via fiberoptic bronchoscopy, and gastric insufflation will be assessed using ultrasound measurement of gastric antral cross-sectional area pre- and post-device placement. Secondary outcomes include postoperative complications such as sore throat, hoarseness and dysphagia.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-19.
Status change: Not Yet Recruiting → Completed 2026-03-23
Trial Details
NCT Number NCT07141498
Lead Sponsor Ankara City Hospital Bilkent
Conditions Laryngeal Mask Airways, Fiberoptic Bronchoscopy (FOB), Elective Surgeries, Gastric Insufflation, Gastric Ultrasound
Enrollment 91 participants
Start Date 2025-08-28
Primary Completion 2025-12-30 (estimated)
Study Completion 2026-01-09 (estimated)
Updated on ClinicalTrials.gov 2026-03-24